Answers are grounded in this paper and cite their sources.
Case report describes TASS after XEN Gel Stent surgery, indicating severe complications can arise unexpectedly.
Introduction: Toxic anterior segment syndrome (TASS) is a rare, sterile, acute inflammatory reaction of the anterior segment following intraocular surgery. Although it is most commonly associated with cataract surgery, it has been reported after a variety of ophthalmic procedures. To our knowledge, no case of TASS following XEN Gel Stent Implantation has been previously described in the literature. Case Presentation: An 85-year-old pseudophakic woman with primary open-angle glaucoma developed TASS after uneventful XEN63 implantation. Within 24 hours postoperatively, the patient presented with diffuse limbus-to-limbus corneal edema, anterior chamber inflammation, and absence of pain or posterior segment involvement. Despite prompt and intensive topical corticosteroid therapy, she developed irreversible corneal decompensation, iris atrophy, and fixed non-reactive mydriasis. No additional cases were identified in the same surgical setting, suggesting a patient or procedure specific trigger. Potential causative factors included intracameral agents (lidocaine, acetylcholine, cefuroxime, viscoelastic material), possible migration of mitomycin C (MMC) through the XEN stent lumen, or an inflammatory response to the gelatin-based device itself. Conclusions: This case demonstrates that TASS can occur following minimally invasive glaucoma surgery (MIGS), including XEN Gel Stent implantation, and may result in severe and irreversible ocular sequelae. It underscores the importance of heightened postoperative vigilance and strict preventive protocols even in procedures perceived as low-risk.
No takes yet. Share an insight, caveat, or question.
Marjalizo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: